Article Text
PDFEditorial
Not just neurological stamp collecting: when rare diagnoses lead to fundamental advances
Statistics from Altmetric.com
Footnotes
Twitter @jmschott
Contributors JMS is the sole author of this paper.
Funding The author acknowledges the support of the UCL/H NIHR Biomedical Research Centre
Competing interests JMS is Chief Medical Officer for Alzheimer's Research UK and Clinical Advisor to the UK Dementia Research Institute.
Provenance and peer review Commissioned; externally peer reviewed by Huw Morris, London, UK.
Linked Articles
- Clinicopathological conference
Read the full text or download the PDF:
Other content recommended for you
- A rare cause of young-onset dementia
- Convergent molecular defects underpin diverse neurodegenerative diseases
- Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
- Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of TREM2
- Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease
- Cerebellar atrophy in neurodegeneration—a meta-analysis
- Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
- Neurofilament light chain as a biomarker in neurological disorders
- 31st Advanced Clinical Neurology Course, Edinburgh 2009: progressive cognitive impairment, behavioural change and upper motor neuron signs in a 57-year-old woman
- Fluid biomarkers in frontotemporal dementia: past, present and future